Cite
HARVARD Citation
Schulze-Koops, H. et al. (2021). Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab. Annals of the rheumatic diseases. 80 (5), p. e67. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Schulze-Koops, H. et al. (2021). Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab. Annals of the rheumatic diseases. 80 (5), p. e67. [Online].